Acadia Pharmaceuticals buy Citigroup Inc.
Start price
13.12.23
/
50%
€20.00
Target price
13.12.24
€35.17
Performance (%)
-17.60%
End price
14.12.24
€16.48
Summary
This prediction ended on 14.12.24 with a price of €16.48. The price of Acadia Pharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.60%. Citigroup_Inc_ has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | 8.030% | 8.030% | 30.146% |
| iShares Core DAX® | 1.659% | 1.586% | 18.113% |
| iShares Nasdaq 100 | 0.381% | 1.900% | 8.877% |
| iShares Nikkei 225® | 2.102% | -1.377% | 13.281% |
| iShares S&P 500 | 0.221% | 1.258% | 3.556% |
Comments by Citigroup_Inc_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $38.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Stopped prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.56
08.08.24
08.08.24
€21.06
08.08.25
08.08.25
43.94%
09.08.25
09.08.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.59
09.05.24
09.05.24
€27.83
09.05.25
09.05.25
8.26%
10.05.25
10.05.25